Hepion Pharmaceuticals Statistics
Total Valuation
HEPA has a market cap or net worth of 6.65 million. The enterprise value is 6.72 million.
| Market Cap | 6.65M |
| Enterprise Value | 6.72M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HEPA has 88.72 million shares outstanding. The number of shares has increased by 251.78% in one year.
| Current Share Class | 88.72M |
| Shares Outstanding | 88.72M |
| Shares Change (YoY) | +251.78% |
| Shares Change (QoQ) | +39.35% |
| Owned by Insiders (%) | 30.71% |
| Owned by Institutions (%) | 14.68% |
| Float | 61.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 5.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91
| Current Ratio | 3.91 |
| Quick Ratio | 3.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -128.97 |
Financial Efficiency
Return on equity (ROE) is -125.64% and return on invested capital (ROIC) is -72.23%.
| Return on Equity (ROE) | -125.64% |
| Return on Assets (ROA) | -61.16% |
| Return on Invested Capital (ROIC) | -72.23% |
| Return on Capital Employed (ROCE) | -219.39% |
| Weighted Average Cost of Capital (WACC) | 13.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.59M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.05% in the last 52 weeks. The beta is 1.65, so HEPA's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | +19.05% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 56.34 |
| Average Volume (20 Days) | 54,355 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.15M |
| Pretax Income | -3.19M |
| Net Income | -3.19M |
| EBITDA | n/a |
| EBIT | -3.15M |
| Earnings Per Share (EPS) | -0.25 |
Balance Sheet
The company has 1.63 million in cash and no debt, with a net cash position of 1.63 million or 0.02 per share.
| Cash & Cash Equivalents | 1.63M |
| Total Debt | n/a |
| Net Cash | 1.63M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 1.28M |
| Book Value Per Share | -0.01 |
| Working Capital | 1.43M |
Cash Flow
| Operating Cash Flow | -1.59M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | -371,661 |
| Free Cash Flow | -1.59M |
| FCF Per Share | -0.02 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HEPA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -251.78% |
| Shareholder Yield | -251.78% |
| Earnings Yield | -47.92% |
| FCF Yield | -23.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 18, 2025. It was a reverse split with a ratio of 0.02.
| Last Split Date | Mar 18, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |